meta-analysis | Q815382 |
systematic review | Q1504425 |
review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1043796683 |
P356 | DOI | 10.1186/CC13760 |
P8608 | Fatcat ID | release_sn2ajunhhrdibenidx56sgdqpu |
P932 | PMC publication ID | 4056761 |
P698 | PubMed publication ID | 24612487 |
P5875 | ResearchGate publication ID | 260681626 |
P50 | author | Naomi Hammond | Q29839624 |
Roman Pfister | Q88713396 | ||
Matthias Kochanek | Q91845528 | ||
Guido Michels | Q118397045 | ||
Mariana Benevides Machado | Q118397101 | ||
Paul R Ingram | Q118397129 | ||
Timo Leygeber | Q118397161 | ||
Elise Cuquemelle | Q118397186 | ||
Enrique Piacentini | Q118397200 | ||
Christian Brun-Buisson | Q41907137 | ||
P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 | Q28260987 | ||
Critically Ill patients with 2009 influenza A(H1N1) in Mexico | Q28261205 | ||
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study | Q28269717 | ||
Emergence of a novel swine-origin influenza A (H1N1) virus in humans | Q29616833 | ||
Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. | Q51898034 | ||
The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. | Q54019322 | ||
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia | Q55966607 | ||
Antibiotic administration in community-acquired pneumonia | Q80332617 | ||
Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia | Q81109888 | ||
Critical care services and 2009 H1N1 influenza in Australia and New Zealand. | Q30381497 | ||
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. | Q30383431 | ||
Procalcitonin and C-reactive protein in severe 2009 H1N1 influenza infection. | Q30384331 | ||
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults | Q30398779 | ||
Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study | Q30400361 | ||
The utility of procalcitonin in diagnosis of H1N1 influenza in intensive care patients. | Q30401757 | ||
Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults | Q30408548 | ||
Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States | Q30415511 | ||
The behavior and diagnostic utility of procalcitonin and five other inflammatory molecules in critically ill patients with respiratory distress and suspected 2009 influenza a H1N1 infection | Q30415731 | ||
Immunopathogenesis of 2009 pandemic influenza | Q30423093 | ||
Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis | Q33980630 | ||
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future | Q34026963 | ||
Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms | Q34028037 | ||
Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis. | Q34294231 | ||
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis | Q34325775 | ||
Nonvalue of sputum culture in the management of lower respiratory tract infections | Q37140266 | ||
Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin | Q37318175 | ||
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain | Q37443062 | ||
Procalcitonin for guidance of antibiotic therapy | Q37747406 | ||
Role of procalcitonin in managing adult patients with respiratory tract infections | Q37999770 | ||
Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the intensive care unit setting | Q39967561 | ||
Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia | Q40512637 | ||
Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study | Q45373299 | ||
Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit | Q47748488 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | protein precursor | Q258658 |
influenza A virus subtype H1N1 | Q161393 | ||
pandemic | Q12184 | ||
influenza pandemic | Q2723958 | ||
bacterial pneumonia | Q3776920 | ||
influenza | Q2840 | ||
calcitonin | Q24783750 | ||
critical illness | Q65807521 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | R44 | |
P577 | publication date | 2014-03-10 | |
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis. | |
P478 | volume | 18 |